From Cornell Research.
A million or more people in the United States suffer from myalgic encephalomyelitis (ME), also known as chronic fatigue syndrome (CFS), but remarkably little is known about the cause of the disease, and effective therapies are lacking. ME/CFS is characterized by debilitating fatigue that is not relieved by rest or due to any other medical condition, as well as a myriad of symptoms, including musculoskeletal pain, headaches, cognitive difficulties, and sleep disturbances.
No simple scientifically validated tests for the illness exist, leading to great uncertainty among clinicians when evaluating patients. The absence of biomarkers for the disease and the lack of available research models for ME/CFS show how little research there has been to date.
To read the rest of this story, click on the link below: